Survey Report: FDA Should Have Been Tougher on Avandia

Courtesy MedPage Today Surveys  Mon, 11/26/2007 - 16:08

Six out of every 10 respondents to a MedPage Today poll said the FDA should have been tougher when it ordered that a myocardial infarction warning be added to the black box warning for heart failure on the rosiglitazone (Avandia) label.


 

More related items

Ventricular Assist Devices Modestly Increase Survival...
DURHAM, N.C. (MedPage Today) -- The use of ventricular assist devices to treat Medicare patients with end-stage heart failure is associated with low short-term survival, high cost, and high...

AHA: Biomarker Beats BNP for Heart Failure Mortality...
NEW ORLEANS (MedPage Today) -- A new biomarker blood test for emergency room use for heart failure patients may improve prediction of 90-day outcomes, researchers said here.

Child Abuse Is Widely Under-Reported
LONDON (MedPage Today) -- Child abuse is more pervasive than records from child- protection services indicate, demonstrating the need to redouble efforts to combat it, researchers here said.

GoFit Ultimate Burst Resistant Core Stability Ball...
The GoFit Ultimate Burst Resistant Core Stability Ball is a fun, yet challenging way to stretch, tone and tighten your body. What makes the GoFit Ball so challenging? Unlike training on a...

Chlorpheniramine Maleate Anti - Allergy Tablets, 4 Mg...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com